UB Paderborn / Katalog / Suche / in CDI

The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies

Journal of biomolecular screening, 2006-04, Vol.11 (3), p.253-261

2006

Volltextzugriff (PDF)

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

European journal of pharmacology, 2001-11, Vol.430 (2-3), p.341-349

2001

Volltextzugriff (PDF)

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.117

2017

Volltextzugriff (PDF)

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats

The international journal of neuropsychopharmacology, 2010-09, Vol.13 (8), p.1021-1033

2010

Volltextzugriff (PDF)

M1 muscarinic receptor signaling in mouse hippocampus and cortex

Brain research, 2002-07, Vol.944 (1), p.82-89

2002

Volltextzugriff (PDF)

Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

The Journal of pharmacology and experimental therapeutics, 1999-08, Vol.290 (2), p.901

1999

Volltextzugriff (PDF)

Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice

Pain (Amsterdam), 1997-04, Vol.70 (2), p.223-228

1997

Volltextzugriff (PDF)

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

Schizophrenia research, 2001-04, Vol.49 (1), p.193-201

2001

Volltextzugriff (PDF)

Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice

European journal of pharmacology, 2000-08, Vol.402 (3), p.241-246

2000

Volltextzugriff (PDF)

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5 R,6 R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

European journal of pharmacology, 1998-09, Vol.356 (2), p.109-119

1998

Volltextzugriff (PDF)

The antibody-capture [ 35S]GTPγS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology

Trends in pharmacological sciences (Regular ed.), 2004-08, Vol.25 (8), p.400-401

DeLapp, Neil W.

2004

Volltextzugriff (PDF)

Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo

Brain research, 2001-10, Vol.916 (1), p.165-171

2001

Volltextzugriff (PDF)

Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist Activity

Journal of medicinal chemistry, 1998-10, Vol.41 (22), p.4378-4384

1998

Volltextzugriff (PDF)

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats

Neuroreport, 1998-10, Vol.9 (15), p.3481-3486

1998

Volltextzugriff (PDF)

The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells

Life sciences (1973), 1995, Vol.57 (12), p.1183-1190

1995

Volltextzugriff (PDF)

The antibody-capture [(35)S]GTPgammaS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology

Trends in pharmacological sciences (Regular ed.), 2004-08, Vol.25 (8), p.400-401

DeLapp, Neil W

2004

Volltextzugriff (PDF)

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.02,6]heptanes as New Potent Muscarinic M1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

Journal of medicinal chemistry, 1999-06, Vol.42 (11), p.1999-2006

1999

Volltextzugriff (PDF)

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic

The Journal of pharmacology and experimental therapeutics, 1997-05, Vol.281 (2), p.876

1997

Volltextzugriff (PDF)

Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity

The Journal of pharmacology and experimental therapeutics, 1997-05, Vol.281 (2), p.884

1997

Volltextzugriff (PDF)

Effect of Basic Fibroblast Growth Factor (bFGF) and Insulin-Like Growth Factors Type I (IGF-I) and Type II (IGF-II) on Adult Human Keratinocyte Growth and Fibronectin Secretion

Journal of investigative dermatology, 1990-06, Vol.94 (6), p.777-780

1990

Volltextzugriff (PDF)

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro

Schizophrenia research, 1999-05, Vol.37 (1), p.107-122

1999

Volltextzugriff (PDF)

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Journal of medicinal chemistry, 1998-01, Vol.41 (1), p.109-116

1998

Volltextzugriff (PDF)

Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic M1 receptor activation

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (20), p.2897-2902

1998

Volltextzugriff (PDF)

Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.946

1999

Volltextzugriff (PDF)

Potential role of muscarinic receptors in schizophrenia

Life sciences (1973), 1999, Vol.64 (6), p.527-534

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats

M1 muscarinic receptor signaling in mouse hippocampus and cortex

Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats

Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5 R,6 R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

The antibody-capture [ 35S]GTPγS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology

Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo

Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist Activity

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats

The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells

The antibody-capture [(35)S]GTPgammaS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.02,6]heptanes as New Potent Muscarinic M1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic

Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity

Effect of Basic Fibroblast Growth Factor (bFGF) and Insulin-Like Growth Factors Type I (IGF-I) and Type II (IGF-II) on Adult Human Keratinocyte Growth and Fibronectin Secretion

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α1-adrenergic receptors in vitro

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic M1 receptor activation

Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay

Potential role of muscarinic receptors in schizophrenia

Suchergebnisse filtern